Cala Health Is Building Momentum By Expanding Affordable Access for Patients with Essential Tremor

BURLINGAME, CA — March 1, 2022 — Cala Health, the bioelectronic medicine leader setting a new
standard of patient care for chronic disease, closed 2021 with significant reimbursement accomplishments for patients. New coding and coverage by commercial and government payors makes it easier for physicians to prescribe and patients to afford Cala Health’s clinically proven treatment for
essential tremor (ET), Cala Trio therapy.